Dr. Reddys Laboratories Ltd.

The United States Food and Drug Administration (USFDA) has completed a pre-approval inspection (PAI) at Dr. Reddy’s Laboratories’ FTO-9 manufacturing facility in Visakhapatnam, Andhra Pradesh. The inspection was conducted from October 8, 2026, to October 9, 2026. The company has been issued a Form 483 with three observations.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.